Table 2 Characteristics of the included patients
From: Development and initial validation of the bronchiectasis exacerbation and symptom tool (BEST)
Characteristic | Mean (sd) or n (%) |
|---|---|
Age | 67.5 (7.4) |
Female sex | 16 (76.2%) |
Comorbidities | |
 Cardiovascular disease | 1 (4.8%) |
 Osteoporosis | 4 (19.1%) |
 Anxiety/depression | 3 (14.3%) |
 Diabetes | 2 (9.5%) |
 FEV1 | 1.76 (0.60) |
 FEV1% predicted | 78.7% (21.7) |
 FVC | 2.74 (0.87) |
Bronchiectasis severity index | |
 Mild | 4 (19.0%) |
 Moderate | 10 (47.6%) |
 Severe | 7 (33.3%) |
 Prior exacerbations | 3.3 (2.0) |
Treatment | |
 Inhaled corticosteroids | 11 (52.4%) |
 Macrolides | 12 (57.1%) |
 Inhaled antibiotics | 1 (4.8%) |
Baseline quality of life and functional status | |
 6 min walk distance | 439 (104) |
 CAT score | 19.1 (6.1) |
 SGRQ | 41.5 (17.0) |